Proteogenomics refines the molecular classification of chronic lymphocytic leukemia
Sophie A. Herbst(German Cancer Research Center), Sascha Dietrich(European Molecular Biology Organization), Katharina Kriegsmann(Getrag (Germany)), Antonella Zucchetto(Centro di Riferimento Oncologico), Peter‐Martin Bruch(European Molecular Biology Organization), Jennifer A. Woyach(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Alexander J. Helmboldt(Max Planck Institute for Nuclear Physics), Richard Rosenquist(Karolinska University Hospital), Georgios Mermelekas(Science for Life Laboratory), Stephan Stilgenbauer(Universität Ulm), Simon Anders(European Molecular Biology Laboratory), Giovanni Del Poeta(University of Rome Tor Vergata), Eugen Tausch(Universität Ulm), Eva C. Schitter(Heidelberg University), Carsten Müller‐Tidow(Heidelberg University), Carmen Herling(University Hospital Leipzig), Wolfgang Huber(European Molecular Biology Laboratory), Marco Herling(Unknown), Husen M. Umer(Science for Life Laboratory), Berit J. Brinkmann(European Molecular Biology Organization), Linus Wahnschaffe(University of Cologne), Nora Liebers(Düsseldorf University Hospital), Janne Lehtiö(Karolinska University Hospital), Larry Mansouri(Uppsala University), Sebastian Scheinost(German Cancer Research Center), Marc Zapatka(German Cancer Research Center), Matthias Ganzinger(Heidelberg University), Angela Lenze(Heidelberg University), Adam S. Kittai(Icahn School of Medicine at Mount Sinai), Cecilia Österholm(Karolinska Institutet), Valter Gattei(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Carolin Kolb(Heidelberg University), Rozbeh Jafari(Science for Life Laboratory), Junyan Lu(Heidelberg University), Tobias Roider(European Molecular Biology Organization), Mark Kriegsmann(CS Diagnostics), Sarah Richter(Heidelberg University), Ying Huang(Linyi University), Peter Dreger(Heidelberg University), Murat Iskar(German Cancer Research Center), Felix Czernilofsky(Heidelberg University), Matthias Stahl(Science for Life Laboratory), Ioannis Siavelis(Science for Life Laboratory), Riccardo Bomben(Centro di Riferimento Oncologico), Xiaofang Cao(Science for Life Laboratory), Thorsten Zenz(Universität Ulm), Mareike Knoll(Heidelberg University), Mattias Vesterlund(Science for Life Laboratory)
Cited by 42
Related Papers
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
|bioRxiv (Cold Spring Harbor Laboratory)|2014|1.8k
iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL
|Blood|2018|1.7k
Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2014|1.7k
Detecting differential usage of exons from RNA-seq data
|Genome Research|2012|1.6k